HIF1A and neoplasm: According to Alexander et al. [62], administering the SDH inhibitor dimethyl malonate (DDM) in myeloid-specific Bmal1 knockout (M-BKO) macrophages could restore a several-fold induction of HIF-1α protein levels, resulting from activation by M1 and suppression of tumor growth.